NCT05325086

Brief Summary

The purpose of the clinical study is to study the effect of health-related quality of Life of information aimed at reducing the impact of a personality trait (openness to experiences) identified as a risk of non-response to pulmonary rehabilitation in patients with chronic respiratory diseases. This study will determine if a specific information focusing on characteristics of openness to experiences personality trait will lead to better benefits than a general information.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

April 5, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 13, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

1.3 years

First QC Date

April 5, 2022

Last Update Submit

July 25, 2023

Conditions

Keywords

Pulmonary rehabilitationPersonality traitsAdapted information

Outcome Measures

Primary Outcomes (1)

  • Differential of health-related quality of life from baseline to PR end-stay

    Assessing differential of health-related quality of life score on St. George's Respiratory Questionnaire (SGRQ) (Jones et al., 1991) from baseline to PR end-stay within and between groups The SGRQ contains 50 questions and evaluates 3 dimensions : symptoms component, activities that cause or are limited by breathlessness and impact component

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

Secondary Outcomes (5)

  • Differential of dyspnea from from baseline to PR end-stay

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

  • Differential of exercise tolerance from from baseline to PR end-stay

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

  • Differential of self-efficacy from from baseline to PR end-stay

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

  • Differential of disease-related thinking from from baseline to PR end-stay

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

  • Differential of disease-related fears from from baseline to PR end-stay

    Changes from baseline (T0) to at the end of the 4-weeks PR (T1)

Study Arms (2)

Adapted information arm

EXPERIMENTAL

In parallel with an inpatient PR program, 4 visits will be carried out: V0 : Inclusion / V1 : Randomization / V2 : Follow-up / V3: End-stay. At V1: * Adapted information to the characteristics of a greater openness to experiences will be delivered to patient. * The following questionnaires will be filled : Big Five Inventory BFI-FR, St. George's Respiratory SGRQ, Dyspnea-12, Self-efficacy for managing chronic disease SEMCD-6, Brief Illness Perception B-IPQ, COPD Anxiety Revised CAF-R, Patient Health PHQ-9, Montreal Cognitive Assessment Mini-MoCA At V2: \*Semi-structured individual interviews will be performed. Questions will relate to the information distributed during V1 (adapted information), allowing to assess the understanding and the appropriation of it. At V3: * The following questionnaires will be filled: SGRQ,Dyspnea-12,SEMCD-6,B-IPQ,CAF-R * In addition, some questions will be asked to verify the adherence to information and the potential contamination bias

Other: Adapted information arm

Neutral information arm

SHAM COMPARATOR

In parallel with an inpatient PR program, 4 visits will be carried out: V0 : Inclusion / V1 : Randomization / V2 : Follow-up / V3: End-stay. At V1: * Neutral information will be delivered to patient. * The following questionnaires will be filled : Big Five Inventory BFI-FR, St. George's Respiratory SGRQ, Dyspnea-12, Self-efficacy for managing chronic disease SEMCD-6, Brief Illness Perception B-IPQ, COPD Anxiety Revised CAF-R, Patient Health PHQ-9, Montreal Cognitive Assessment Mini-MoCA At V2: \*Semi-structured individual interviews will be performed. Questions will relate to the information distributed during V1 (neutral information), allowing to assess the understanding and the appropriation of it. At V3: * The following questionnaires will be filled: SGRQ,Dyspnea-12,SEMCD-6,B-IPQ,CAF-R * In addition, some questions will be asked to verify the adherence to information and the potential contamination bias

Other: Neutral information arm

Interventions

A adapted booklet will be delivered to patients at the start of the stay. This booklet contains adapted information about the pulmonary rehabilitation targetting the characteristics of the openness to experiences personality traits

Adapted information arm

A neutral booklet will be delivered to patients at the start of the stay. This booklet contains neutral information about the pulmonary rehabilitation

Neutral information arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted for a 4-week inpatient pulmonary rehabilitation program Chronic respiratory disease diagnosis 18 and 80 years old Reading and writing skills Oral consent

You may not qualify if:

  • Inability to participate to exercise training Inability to answer a questionnaire Severe or unstable heart disease, orthopedic, neurologic or psychiatric comorbidities Recent exacerbation (\<4 weeks) Pregnant and breastfeeding women Protected adults, pregnant women Participation in another study, with the exception of observational studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinique du Souffle le Pontet

Hauteville-Lompnes, 01110, France

Location

Clinique du Souffle Les Clarines

Riom-ès-Montagnes, France

Location

Study Officials

  • Benjamin EICHENAUER

    Korian

    PRINCIPAL INVESTIGATOR
  • Nelly HERAUD

    Korian

    STUDY DIRECTOR
  • Brice CANADA

    Université de Lyon

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 13, 2022

Study Start

April 5, 2022

Primary Completion

July 25, 2023

Study Completion

July 25, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations